Straits Times Index
3,261.41 +36.24 (+1.12%) Nikkei
37,552.16 +113.55 (+0.30%) Hang Seng
16,798.61 +286.92 (+1.74%) FTSE 100
8,023.87 +128.02 (+1.62%) Bitcoin USD
66,546.59 +191.11 (+0.29%) CMC Crypto 200
1,402.93 -11.83 (-0.84%)
JNJ Jan 2025 115.000 put
| Previous close | 1.0000 |
| Open | 1.0000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 115.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.0000 - 1.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Insider Monkey10 Best Performing Biotech ETFs in 2024
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]
ZacksJohnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Reuters
RPT-Contaminated cough syrup in Africa no longer available - WHO
A contaminated batch of Benylin Paediatric Syrup is no longer available in the African countries where it was sold, the World Health Organization said on Monday. Earlier this month, Nigeria recalled a batch of the children's cough and allergy medicine after tests found that it contained unacceptable levels of the toxin, diethylene glycol. Five other African countries have also pulled the product from shelves - Kenya, Rwanda, Tanzania, Zimbabwe and South Africa, where the drug was made.
